부산대학교 도서관

A Leila Sarvestani; Samantha Ruff; Kirsten Remmert; Martha Teke; Emily Verbus; Areeba Saif; Marcial Garmendia-Cedillos; Alex Rossi; Ashley Rainey; Krystle Nomie; Surajit Sinha; Michael M. Wach; Carrie Ryan; Stephanie N. Gregory; Priyanka Desai; Abir K. Panda; Emily C. Smith; Reed Ayabe; James D. McDonald; Shreya Gupta; Tracey Pu; Tahsin Khan; Jacob Lambdin; Kenneth Luberice; Stephanie C. Lux; Hanna Hong; Imani Alexander; Sarfraz R. Akmal; Shahyan Rehman; Sophia Xiao; Jason Ho; Justine Burke; Cathleen E. Hannah; Alexandra Livanova; Andrey Tyshevich; Stanislav Kurpe; Andrey Kravets; Basim Salem; Daniil Vibe; Arina Tkachukv; Anna Belozerova; Aleksandr Sarachakov; Evgeny Barykin; Vladimir Kushnarev; Ekaterina Postovalova; Alexander Bagaev; Noemi Kedei; Maria Hernandez; Baktiar Karim; Donna Butcher; Jennifer Matta; Michael Kelly; Jatinder Singh; Todd D. Prickett; James Hodge; Thorkell Andresson; Michael B. Yaffe; Ethan M. Shevach; David Kleiner; Jeremy L. Davis; Andrew M. Blakely; Jonathan M. Hernandez

Artem Tarasov; Vladimir Kushnarev; Angelina Khachatryan; Kirill Kryukov; Anna Novokreshchenova; Linda Balabanian; Konstantin Chernyshov; Aida Aukhadieva; Marina Voropaeva; Aleksei Shevkoplias; Lev Bedniagin; Anna Ogloblina; Nathan Fowler; Krystle Nomie; Alexander Bagaev; Jochen K Lennerz; Neeharika S Makani; Gregory M Cote; Sant P Chawla; Anthony P Conley; John Livingston

Regular and Young Investigator Award Abstracts. :A210-A211

Dai Y; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.; Kizhakeyil A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chihara D; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li X; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Y; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sainz Zuniga TP; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wilson A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henderson J; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vibe D; BostonGene Corporation, Waltham, MA, USA.; Petrosyants A; BostonGene Corporation, Waltham, MA, USA.; Jacobson C; BostonGene Corporation, Waltham, MA, USA.; Sarachakov A; BostonGene Corporation, Waltham, MA, USA.; Nomie K; BostonGene Corporation, Waltham, MA, USA.; Kryukov K; BostonGene Corporation, Waltham, MA, USA.; Bagaev A; BostonGene Corporation, Waltham, MA, USA.; Chauhan A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.; Vega F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang L; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. lwang22@mdanderson.org.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; The Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; Green MR; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. mgreen5@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. mgreen5@mdanderson.org.; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA. mgreen5@mdanderson.org.; Lymphoid Malignancies Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mgreen5@mdanderson.org.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Russell K. Pachynski; Eric H. Kim; Natalia Miheecheva; Nikita Kotlov; Akshaya Ramachandran; Ekaterina Postovalova; Ilia Galkin; Viktor Svekolkin; Yang Lyu; Qiong Zou; Dengfeng Cao; Joseph Gaut; Joseph E. Ippolito; Alexander Bagaev; Maria Bruttan; Olga Gancharova; Krystle Nomie; Maria Tsiper; Gerald L. Andriole; Ravshan Ataullakhanov; James J. Hsieh

Clinical Cancer Research. 27:3478-3490

Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lian J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cai Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McIntosh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dai E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Santos D; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Badillo M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Leeming A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hartig K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bigcal J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhou J; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriquez A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thirumurthi S; Department of Gastroenterology, Hepathology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wagner-Bartak N; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hill H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nomie K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. lwang22@mdanderson.org.; Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

James J. Hsieh; Ravshan Ataullakhanov; Gerald L. Andriole; Maria Tsiper; Krystle Nomie; Olga Gancharova; Maria Bruttan; Alexander Bagaev; Joseph E. Ippolito; Joseph Gaut; Dengfeng Cao; Qiong Zou; Yang Lyu; Viktor Svekolkin; Ilia Galkin; Ekaterina Postovalova; Akshaya Ramachandran; Nikita Kotlov; Natalia Miheecheva; Eric H. Kim; Russell K. Pachynski

James J. Hsieh; Ravshan Ataullakhanov; Gerald L. Andriole; Maria Tsiper; Krystle Nomie; Olga Gancharova; Maria Bruttan; Alexander Bagaev; Joseph E. Ippolito; Joseph Gaut; Dengfeng Cao; Qiong Zou; Yang Lyu; Viktor Svekolkin; Ilia Galkin; Ekaterina Postovalova; Akshaya Ramachandran; Nikita Kotlov; Natalia Miheecheva; Eric H. Kim; Russell K. Pachynski

James J. Hsieh; Ravshan Ataullakhanov; Gerald L. Andriole; Maria Tsiper; Krystle Nomie; Olga Gancharova; Maria Bruttan; Alexander Bagaev; Joseph E. Ippolito; Joseph Gaut; Dengfeng Cao; Qiong Zou; Yang Lyu; Viktor Svekolkin; Ilia Galkin; Ekaterina Postovalova; Akshaya Ramachandran; Nikita Kotlov; Natalia Miheecheva; Eric H. Kim; Russell K. Pachynski

K. Danilov; D. Bansal; C. Ward; A. Al-Obaidi; T. Pluard; A. Tarasov; I. Valiev; V. Kushnarev; A. Makarova; A. Butusova; A. Love; K. Nomie; A. Bagaev; J. Subramanian; N. Fowler

Journal of Thoracic Oncology. 18:S241

Jain P; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pjain@mdanderson.org.; Nomie K; BostonGene Corporation, Boston, MA, USA.; Kotlov N; BostonGene Corporation, Boston, MA, USA.; Segodin V; BostonGene Corporation, Boston, MA, USA.; Hill H; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ok CY; Department of Hematopathology at The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fetooh A; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology at The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vega F; Department of Hematopathology at The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bagaev A; BostonGene Corporation, Boston, MA, USA.; Fowler N; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; BostonGene Corporation, Boston, MA, USA.; Flowers CR; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang M; Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Jain, P.; Nomie, K.; Kotlov, N.; Hill, H.; Ok, C. Y.; Fetooh, A.; Kanagal‐Shamanna, R.; Vega, F.; Fowler, N.; Wang, M.

Publisher: Wiley-Blackwell ISSN: 0278-0232

P. Jain; R. Kanagal‐Shamanna; S. Zhang; C. Ok; G. Nogueras Gonzalez; O. Gonzalez‐Pagan; A. Ghorab; P. Boddu; W. Chen; H. Ju Lee; K. Nomie; L. Fayad; J. Westin; L. Nastoupil; K. Patel; S. Ahmed; S.P. Iyer; S. Parmar; R. Champlin; S. Neelapu; J.L. Medeiros; J. Romaguera; N. Fowler; L. Wang; M.L. Wang

Hematological Oncology. 37:238-239

Dyikanov D; BostonGene, Corp., Waltham, MA, USA.; Zaitsev A; BostonGene, Corp., Waltham, MA, USA.; Vasileva T; BostonGene, Corp., Waltham, MA, USA.; Wang I; BostonGene, Corp., Waltham, MA, USA.; Sokolov AA; BostonGene, Corp., Waltham, MA, USA.; Bolshakov ES; BostonGene, Corp., Waltham, MA, USA.; Frank A; BostonGene, Corp., Waltham, MA, USA.; Turova P; BostonGene, Corp., Waltham, MA, USA.; Golubeva O; BostonGene, Corp., Waltham, MA, USA.; Gantseva A; BostonGene, Corp., Waltham, MA, USA.; Kamysheva A; BostonGene, Corp., Waltham, MA, USA.; Shpudeiko P; BostonGene, Corp., Waltham, MA, USA.; Krauz I; BostonGene, Corp., Waltham, MA, USA.; Abdou M; BostonGene, Corp., Waltham, MA, USA.; Chasse M; BostonGene, Corp., Waltham, MA, USA.; Conroy T; BostonGene, Corp., Waltham, MA, USA.; Merriam NR; BostonGene, Corp., Waltham, MA, USA.; Alesse JE; BostonGene, Corp., Waltham, MA, USA.; English N; BostonGene, Corp., Waltham, MA, USA.; Shpak B; BostonGene, Corp., Waltham, MA, USA.; Shchetsova A; BostonGene, Corp., Waltham, MA, USA.; Tikhonov E; BostonGene, Corp., Waltham, MA, USA.; Filatov I; BostonGene, Corp., Waltham, MA, USA.; Radko A; BostonGene, Corp., Waltham, MA, USA.; Bolshakova A; BostonGene, Corp., Waltham, MA, USA.; Kachalova A; BostonGene, Corp., Waltham, MA, USA.; Lugovykh N; BostonGene, Corp., Waltham, MA, USA.; Bulahov A; BostonGene, Corp., Waltham, MA, USA.; Kilina A; BostonGene, Corp., Waltham, MA, USA.; Asanbekov S; BostonGene, Corp., Waltham, MA, USA.; Zheleznyak I; BostonGene, Corp., Waltham, MA, USA.; Skoptsov P; BostonGene, Corp., Waltham, MA, USA.; Alekseeva E; BostonGene, Corp., Waltham, MA, USA.; Johnson JM; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.; Curry JM; Department of Otolaryngology Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.; Linnenbach AJ; Department of Otolaryngology Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.; South AP; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.; Yang E; The Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Morozov K; BostonGene, Corp., Waltham, MA, USA.; Terenteva A; BostonGene, Corp., Waltham, MA, USA.; Nigmatullina L; BostonGene, Corp., Waltham, MA, USA.; Fastovetz D; BostonGene, Corp., Waltham, MA, USA.; Bobe A; BostonGene, Corp., Waltham, MA, USA.; Balabanian L; BostonGene, Corp., Waltham, MA, USA.; Nomie K; BostonGene, Corp., Waltham, MA, USA.; Yong ST; BostonGene, Corp., Waltham, MA, USA.; Davitt CJH; BostonGene, Corp., Waltham, MA, USA.; Ryabykh A; BostonGene, Corp., Waltham, MA, USA.; Kudryashova O; BostonGene, Corp., Waltham, MA, USA.; Tazearslan C; BostonGene, Corp., Waltham, MA, USA.; Bagaev A; BostonGene, Corp., Waltham, MA, USA.; Fowler N; BostonGene, Corp., Waltham, MA, USA.; Luginbuhl AJ; Department of Otolaryngology Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.; Ataullakhanov RI; BostonGene, Corp., Waltham, MA, USA.; Goldberg MF; BostonGene, Corp., Waltham, MA, USA. Electronic address: michael.goldberg@bostongene.com.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lian J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cai Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McIntosh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dai E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Santos D; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Badillo M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Leeming A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hartig K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bigcal J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhou J; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriquez A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thirumurthi S; Department of Gastroenterology, Hepathology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wagner-Bartak N; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hill H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nomie K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. lwang22@mdanderson.org.; Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Kotlov, N.; Shaposhnikov, K.; Tazearslan, C.; Chasse, M.; Baisangurov, A.; Podsvirova, S.; Fernandez, D.; Abdou, M.; Kaneunyenye, L.; Morgan, K.; Cheremushkin, I.; Zemskiy, P.; Chelushkin, M.; Sorokina, M.; Belova, E.; Khorkova, S.; Lozinsky, Y.; Nuzhdina, K.; Vasileva, E.; Kravchenko, D.; Suryamohan, K.; Nomie, K.; Curran, J.; Fowler, N.; Bagaev, A.

In: Communications Biology. (Communications Biology, December 2024, 7(1))

M. Wang; P. Jain; S. Zhang; K. Nomie; L. Wang; O. Oriabure; G. Nogueras Gonzales; L. Zhang; N. Wagner‐Bartak; F. Hagemeister; F. Samaniego; J. Westin; H.J. Lee; L. Nastoupil; C. Ok; R. Kanagal‐Shamanna; W. Chen; S. Thirumurthi; D. Santos; M. Badillo; L. Fayad; S. Neelapu; N. Fowler; J. Romaguera

Hematological Oncology. 37:42-43

Godfrey J; Hematology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.; Chen X; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Sunseri N; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Cooper A; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Yu J; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Varlamova A; BostonGene, Waltham, Massachusetts, USA.; Zarubin D; BostonGene, Waltham, Massachusetts, USA.; Popov Y; BostonGene, Waltham, Massachusetts, USA.; Jacobson C; BostonGene, Waltham, Massachusetts, USA.; Postovalova E; BostonGene, Waltham, Massachusetts, USA.; Xiang Z; BostonGene, Waltham, Massachusetts, USA.; Nomie K; BostonGene, Waltham, Massachusetts, USA.; Bagaev A; BostonGene, Waltham, Massachusetts, USA.; Venkataraman G; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Zha Y; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Tumuluru S; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Smith SM; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.; Kline JP; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA jkline@medicine.bsd.uchicago.edu.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Zhao S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Navsaria L; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nomie K; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hill HA; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jiang C; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Yao Y; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nastoupil L; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Westin J; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fayad L; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nair R; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Steiner R; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ahmed S; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Samaniego F; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Iyer SP; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Oriabure O; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Chen W; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Badillo M; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Moghrabi O; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Aranda J; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Thirumurthi S; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Xu G; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Neelapu S; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Flowers CR; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Romaguera J; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fowler N; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wang ML; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jain P; Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Sorokina M; BostonGene Corporation, Waltham, MA.; Stupichev D; BostonGene Corporation, Waltham, MA.; Lyu Y; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.; Ramachandran A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.; Miheecheva N; BostonGene Corporation, Waltham, MA.; Brown JH; BostonGene Corporation, Waltham, MA.; Nomie K; BostonGene Corporation, Waltham, MA.; Postovalova E; BostonGene Corporation, Waltham, MA.; Bagaev A; BostonGene Corporation, Waltham, MA.; Tsiper M; BostonGene Corporation, Waltham, MA.; Hsieh JJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO. Electronic address: jhsieh@wustl.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Radtke AJ; Lymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD 20892, USA. Electronic address: andrea.radtke@nih.gov.; Postovalova E; BostonGene, Waltham, MA 02453, USA.; Varlamova A; BostonGene, Waltham, MA 02453, USA.; Bagaev A; BostonGene, Waltham, MA 02453, USA.; Sorokina M; BostonGene, Waltham, MA 02453, USA.; Kudryashova O; BostonGene, Waltham, MA 02453, USA.; Meerson M; BostonGene, Waltham, MA 02453, USA.; Polyakova M; BostonGene, Waltham, MA 02453, USA.; Galkin I; BostonGene, Waltham, MA 02453, USA.; Svekolkin V; BostonGene, Waltham, MA 02453, USA.; Isaev S; BostonGene, Waltham, MA 02453, USA.; Wiebe D; BostonGene, Waltham, MA 02453, USA.; Sharun A; BostonGene, Waltham, MA 02453, USA.; Sarachakov A; BostonGene, Waltham, MA 02453, USA.; Perelman G; BostonGene, Waltham, MA 02453, USA.; Lozinsky Y; BostonGene, Waltham, MA 02453, USA.; Yaniv Z; Bioinformatics and Computational Bioscience Branch, NIAID, NIH, Bethesda, MD 20892, USA.; Lowekamp BC; Bioinformatics and Computational Bioscience Branch, NIAID, NIH, Bethesda, MD 20892, USA.; Speranza E; Lymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD 20892, USA; Florida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port Saint Lucie, FL 34987, USA.; Yao L; Li Yao Visuals, Rockville, MD 20855, USA.; Pittaluga S; Laboratory of Pathology, NCI, NIH, Bethesda, MD 20892, USA.; Shaffer AL 3rd; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA; Tumor Targeted Delivery, Heme Malignancy Target Discovery Group, AstraZeneca, Gaithersburg, MD 20878, USA.; Jonigk D; Institute of Pathology, Aachen Medical University, RWTH Aachen, 52074 Aachen, Germany; German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 30625 Hannover, Germany.; Phelan JD; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Davies-Hill T; Laboratory of Pathology, NCI, NIH, Bethesda, MD 20892, USA.; Huang DW; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Ovcharov P; BostonGene, Waltham, MA 02453, USA.; Nomie K; BostonGene, Waltham, MA 02453, USA.; Nuzhdina E; BostonGene, Waltham, MA 02453, USA.; Kotlov N; BostonGene, Waltham, MA 02453, USA.; Ataullakhanov R; BostonGene, Waltham, MA 02453, USA.; Fowler N; BostonGene, Waltham, MA 02453, USA.; Kelly M; CCR Single Analysis Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.; Muppidi J; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Davis JL; Surgical Oncology Program, Metastasis Biology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.; Hernandez JM; Surgical Oncology Program, Metastasis Biology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.; Wilson WH; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Jaffe ES; Laboratory of Pathology, NCI, NIH, Bethesda, MD 20892, USA.; Staudt LM; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Roschewski M; Lymphoid Malignancies Branch, NCI, NIH, Bethesda, MD 20892, USA.; Germain RN; Lymphocyte Biology Section and Center for Advanced Tissue Imaging, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD 20892, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE